CN102712956A - 肠易激综合征的诊断方法 - Google Patents

肠易激综合征的诊断方法 Download PDF

Info

Publication number
CN102712956A
CN102712956A CN2010800605536A CN201080060553A CN102712956A CN 102712956 A CN102712956 A CN 102712956A CN 2010800605536 A CN2010800605536 A CN 2010800605536A CN 201080060553 A CN201080060553 A CN 201080060553A CN 102712956 A CN102712956 A CN 102712956A
Authority
CN
China
Prior art keywords
ibs
sample
marker
level
ibs marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800605536A
Other languages
English (en)
Chinese (zh)
Inventor
H·龚
S·L·王
S·辛格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Prometheus Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometheus Laboratories Inc filed Critical Prometheus Laboratories Inc
Publication of CN102712956A publication Critical patent/CN102712956A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CN2010800605536A 2009-10-30 2010-10-29 肠易激综合征的诊断方法 Pending CN102712956A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US25671709P 2009-10-30 2009-10-30
US61/256,717 2009-10-30
US26458809P 2009-11-25 2009-11-25
US61/264,588 2009-11-25
US32617610P 2010-04-20 2010-04-20
US61/326,176 2010-04-20
PCT/US2010/054810 WO2011053831A1 (en) 2009-10-30 2010-10-29 Methods for diagnosing irritable bowel syndrome

Publications (1)

Publication Number Publication Date
CN102712956A true CN102712956A (zh) 2012-10-03

Family

ID=43922588

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800605536A Pending CN102712956A (zh) 2009-10-30 2010-10-29 肠易激综合征的诊断方法

Country Status (14)

Country Link
US (1) US20120315630A1 (enExample)
EP (1) EP2494074A4 (enExample)
JP (1) JP2013509593A (enExample)
KR (1) KR20120101038A (enExample)
CN (1) CN102712956A (enExample)
AU (1) AU2010313292A1 (enExample)
BR (1) BR112012010108A2 (enExample)
CA (1) CA2778539A1 (enExample)
IL (1) IL219317A0 (enExample)
MX (1) MX2012005015A (enExample)
PH (1) PH12012500850A1 (enExample)
RU (1) RU2012122180A (enExample)
WO (1) WO2011053831A1 (enExample)
ZA (1) ZA201203718B (enExample)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103175971A (zh) * 2013-02-28 2013-06-26 苏州和锐医药科技有限公司 一种IgA抗体检测试剂盒
CN104884959A (zh) * 2012-10-05 2015-09-02 雀巢产品技术援助有限公司 作为ibs的诊断标志物的微生物组抗体、应激因子和肥大细胞标志物
CN106446599A (zh) * 2015-08-11 2017-02-22 中国科学院青岛生物能源与过程研究所 一种筛选婴幼儿龋病的口腔致病性生物标记物的方法
CN106990057A (zh) * 2017-05-05 2017-07-28 贵州普洛迈德生物工程有限公司 一种检测5‑羟吲哚乙酸试剂及制备方法
CN105687225B (zh) * 2016-02-26 2018-07-06 四川好医生攀西药业有限责任公司 一种治疗肠易激综合征的药物组合物及其制备方法和应用
CN109716134A (zh) * 2016-03-24 2019-05-03 莫洛克有限公司 败血症的检测
CN111784683A (zh) * 2020-07-10 2020-10-16 天津大学 病理切片检测方法及装置、计算机设备及存储介质
US10817778B2 (en) 2016-06-27 2020-10-27 International Business Machines Corporation Customized cooking utilizing deep learning neuromorphic computing of hyperspectral input
CN111905111A (zh) * 2020-09-16 2020-11-10 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
CN112921100A (zh) * 2019-12-06 2021-06-08 宁波海尔施基因科技有限公司 一种检测人类压力敏感度基因型的试剂盒和方法
CN114599382A (zh) * 2019-10-17 2022-06-07 哥本哈根大学 Tacr2的激动剂
CN115328117A (zh) * 2022-07-15 2022-11-11 大理大学 基于强化学习的蛋白质动态配体通道最优路径分析方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857503B2 (ja) * 2010-07-29 2016-02-10 小野薬品工業株式会社 ストレス性疾患のバイオマーカー
WO2012158831A1 (en) 2011-05-16 2012-11-22 Prometheus Laboratories Inc. Performance of a biomarker panel for irritable bowel syndrome
NZ702643A (en) * 2012-05-19 2016-06-24 Falk Pharma Gmbh Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate
WO2014082034A1 (en) * 2012-11-26 2014-05-30 Lexicon Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome
EP3800470A1 (en) * 2013-03-15 2021-04-07 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
RU2015155552A (ru) * 2013-05-24 2017-06-27 Нестек С.А. Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника
CA2930330A1 (en) * 2013-12-27 2015-07-02 Dignity Health Diagnosing and treating alzheimer's disease
JP6713723B2 (ja) * 2014-02-18 2020-06-24 小野薬品工業株式会社 過敏性腸症候群の診断用バイオマーカー
US10392665B2 (en) 2015-06-19 2019-08-27 Sera Prognostics, Inc. Biomarker pairs for predicting preterm birth
AU2017325986B2 (en) * 2016-09-16 2023-12-14 Takeda Pharmaceutical Company Limited Metabolite biomarkers for diseases associated with the contact activation system
RU2668496C2 (ru) * 2017-03-16 2018-10-01 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Способ диагностики тяжести течения синдрома раздраженного кишечника
US11662351B2 (en) 2017-08-18 2023-05-30 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
US11488699B1 (en) 2018-12-09 2022-11-01 Cerner Innovation, Inc. Microbiota activity sensor and decision support tool
US11842795B1 (en) * 2018-12-17 2023-12-12 Cerner Innovation, Inc. Irritable bowel syndrome diagnostic sensor and decision support tool
KR102330639B1 (ko) * 2019-01-18 2021-11-24 주식회사 천랩 과민성대장증후군 특이적 미생물 바이오마커와 이를 이용하여 과민성대장증후군의 위험도를 예측하는 방법
US20220146527A1 (en) * 2019-09-17 2022-05-12 Chang Gung University Method of creating characteristic profiles of mass spectra and identification model for analyzing and identifying features of microorganisms
EP3913371A1 (en) * 2020-05-18 2021-11-24 Neuroimmun GmbH Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions
US20220208375A1 (en) * 2020-12-29 2022-06-30 Kpn Innovations, Llc. System and method for generating a digestive disease functional program

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303617B1 (en) * 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
WO2002020841A2 (en) * 2000-09-06 2002-03-14 Glaxo Group Limited 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2778685B1 (en) * 2009-06-25 2017-04-26 Nestec S.A. Methods for diagnosing irritable bowel syndrome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303617B1 (en) * 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
WO2002020841A2 (en) * 2000-09-06 2002-03-14 Glaxo Group Limited 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
HEATHER L., ET AL.: "Stress Impairs Murine Intestinal Barrier Function: Improvement by Glucagon-Like Peptide-2", 《THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS》, vol. 314, no. 1, 31 July 2005 (2005-07-31), pages 214 - 220 *
I POSSERUD, ET AL.: "Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress", 《GUT》, vol. 53, no. 8, 31 August 2004 (2004-08-31), pages 1102 - 1108 *
I. JILL KAROLYI, ET AL.: "Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice", 《PROC. NATL. ACAD. SCI. USA》, vol. 96, 30 September 1999 (1999-09-30), pages 11595 - 11600 *
JORG M. LAUFFER， ET AL.: "Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract", 《REGULATORY PEPTIDES》, vol. 84, no. 13, 31 October 1999 (1999-10-31), pages 1 - 12 *
M SIMRÉN, ET AL.: "An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome", 《GUT》, vol. 48, no. 1, 31 January 2001 (2001-01-31), pages 20 - 27 *
M. D. GERSHON，ET AL.: "RADIOISOTOPIC STUDIES OF THE BINDING, EXCHANGE, AND DISTRIBUTION OF 5-HYDROXYTRYPTAMINE SYNTHESIZED FROM ITS RADIOACTIVE PRECURSOR", 《J. PHYSIOL.》, vol. 186, no. 2, 31 October 1966 (1966-10-31), pages 451 - 476 *
SIMON P. DUNLOP， ET AL.: "Abnormalities of 5-Hydroxytryptamine Metabolism in Irritable Bowel Syndrome", 《CLINICAL GASTROENTEROLOGY AND HEPATOLOGY》, vol. 3, no. 4, 30 April 2005 (2005-04-30), pages 349 - 357, XP005120725, DOI: doi:10.1016/S1542-3565(04)00726-8 *
T O C KILKENS, ET AL.: "Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls", 《GUT》, vol. 53, no. 12, 31 December 2004 (2004-12-31), pages 1794 - 1800 *
Y. TACHE´ ,ET AL.: "CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications alterations of colonic function and viscerosensitivity: implications", 《BRITISH JOURNAL OF PHARMACOLOGY》, vol. 141, no. 8, 30 April 2004 (2004-04-30), pages 1321 - 1330 *
YOSHIKO KISHMOTO, ET AL.: "Synthesis and Properties of Serotonin O-Sulfate", 《THE JOURNAL OF BIOCHEMISTRY》, vol. 49, no. 5, 31 May 1961 (1961-05-31), pages 436 - 440 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884959A (zh) * 2012-10-05 2015-09-02 雀巢产品技术援助有限公司 作为ibs的诊断标志物的微生物组抗体、应激因子和肥大细胞标志物
CN104884959B (zh) * 2012-10-05 2017-12-01 雀巢产品技术援助有限公司 作为ibs的诊断标志物的微生物组抗体、应激因子和肥大细胞标志物
CN103175971B (zh) * 2013-02-28 2016-10-05 苏州和锐医药科技有限公司 一种IgA抗体检测试剂盒
CN103175971A (zh) * 2013-02-28 2013-06-26 苏州和锐医药科技有限公司 一种IgA抗体检测试剂盒
CN106446599A (zh) * 2015-08-11 2017-02-22 中国科学院青岛生物能源与过程研究所 一种筛选婴幼儿龋病的口腔致病性生物标记物的方法
CN105687225B (zh) * 2016-02-26 2018-07-06 四川好医生攀西药业有限责任公司 一种治疗肠易激综合征的药物组合物及其制备方法和应用
CN109716134A (zh) * 2016-03-24 2019-05-03 莫洛克有限公司 败血症的检测
CN109716134B (zh) * 2016-03-24 2022-12-02 莫洛迪克有限公司 败血症的检测
US10817778B2 (en) 2016-06-27 2020-10-27 International Business Machines Corporation Customized cooking utilizing deep learning neuromorphic computing of hyperspectral input
CN106990057A (zh) * 2017-05-05 2017-07-28 贵州普洛迈德生物工程有限公司 一种检测5‑羟吲哚乙酸试剂及制备方法
CN114599382A (zh) * 2019-10-17 2022-06-07 哥本哈根大学 Tacr2的激动剂
CN112921100A (zh) * 2019-12-06 2021-06-08 宁波海尔施基因科技有限公司 一种检测人类压力敏感度基因型的试剂盒和方法
CN111784683A (zh) * 2020-07-10 2020-10-16 天津大学 病理切片检测方法及装置、计算机设备及存储介质
CN111784683B (zh) * 2020-07-10 2022-05-17 天津大学 病理切片检测方法及装置、计算机设备及存储介质
CN111905111A (zh) * 2020-09-16 2020-11-10 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
CN111905111B (zh) * 2020-09-16 2023-03-31 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
CN115328117A (zh) * 2022-07-15 2022-11-11 大理大学 基于强化学习的蛋白质动态配体通道最优路径分析方法

Also Published As

Publication number Publication date
US20120315630A1 (en) 2012-12-13
ZA201203718B (en) 2014-11-26
RU2012122180A (ru) 2013-12-10
MX2012005015A (es) 2012-06-12
IL219317A0 (en) 2012-06-28
PH12012500850A1 (en) 2013-01-07
JP2013509593A (ja) 2013-03-14
CA2778539A1 (en) 2011-05-05
AU2010313292A1 (en) 2012-06-07
EP2494074A4 (en) 2013-06-12
KR20120101038A (ko) 2012-09-12
BR112012010108A2 (pt) 2016-05-31
WO2011053831A1 (en) 2011-05-05
EP2494074A1 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
CN102712956A (zh) 肠易激综合征的诊断方法
JP5571951B2 (ja) 試料が過敏性腸症候群と関連するか否かを決定する分類方法
JP6634544B2 (ja) 過敏性腸症候群の診断方法
EP2710383B1 (en) Performance of a biomarker panel for irritable bowel syndrome

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
ASS Succession or assignment of patent right

Owner name: NESTLE PRODUCTS TECHNICAL ASSISTANCE CO., LTD.

Free format text: FORMER OWNER: PROMETHEUS LAB INC.

Effective date: 20121012

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20121012

Address after: Vevey

Applicant after: Nestle Products Technical Assistance Co., Ltd.

Address before: American California

Applicant before: Prometheus Lab Inc.

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121003